Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
[Application of laser therapy in the physiotherapy of patients with multiple sclerosis].
Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients.
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
[Biomarkers in multiple sclerosis].
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
Response: relationship between vitamin D and depression in multiple sclerosis.
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.
7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study.
Dark microglia: A new phenotype predominantly associated with pathological states.
Afferent visual pathways in multiple sclerosis: a review.
Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis.
Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
Home-based exercise program and fall-risk reduction in older adults with multiple sclerosis: phase 1 randomized controlled trial.
Antidepressant activity of fingolimod in mice.
Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values: Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D.
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.
Imatinib-induced amelioration of neurologic deficits in a rare case of simultaneous association of missed multiple sclerosis and chronic myeloblastic leukemia.
Letter to the Editor.
Clonal Expansion of Mitochondrial DNA Deletions and the Progression of Multiple Sclerosis.
Lipid microarrays identify key mediators of autoimmune brain inflammation.
Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti-aquaporin 4 Antibody: A Case Report and Literature Review.
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.
No Help from Dalfampridine in MS-Related Optic Neuritis
Pages
« first
‹ previous
…
229
230
231
232
233
234
235
236
237
…
next ›
last »